# Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors

> **NCT02636556** · NA · COMPLETED · sponsor: **Fudan University** · enrollment: 56 (actual)

## Conditions studied

- Thymoma and Thymic Carcinoma

## Interventions

- **RADIATION:** concurrent chemoradiation

## Key facts

- **NCT ID:** NCT02636556
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2018-08
- **Final completion:** 2020-02
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636556, "Chemoradiotherapy for Limited Advanced Unresectable Thymic Epithelial Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02636556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*